Endonovo Therapeutics (OTCQB: ENDV) develops,
manufactures and distributes innovative medical devices focused on the rapid
healing of wounds and reduction of pain, edema and inflammation on and in the
human body. The company’s SofPulse® Electroceutical® Therapy device employs
targeted microcurrents to transmit gentle pulses to the tissue to help ease
swelling and accelerate the natural recovery process. The device was recently
reviewed in a video by Dr. Jane Graenber of the Foot & Ankle Wellness
Center following a tendon reconstruction surgery. In the video, Dr. Graenber
discusses her experience with ENDV’s SofPulse®. “Here I am, late in the evening
on my first post-op day, and I haven’t had any pain pills yet,” Dr. Graenber
stated in the video. “This was a pretty big surgery and I’m really very
comfortable. I’m giving credit to a good surgeon but also a new device
revolutionizing pain after surgery.”
To view the full video, visit http://ibn.fm/2HNGa
About Endonovo Therapeutics Inc.
Endonovo Therapeutics is a commercial-stage developer of
noninvasive wearable Electroceuticals® therapeutic devices. The company’s
current portfolio of commercial and clinical-stage wearable Electroceuticals®
therapeutic devices addresses wound healing, pain, postsurgical pain and edema,
cardiovascular disease, chronic kidney disease, and central nervous system
(“CNS”) disorders, including traumatic brain injury (“TBI”), acute concussions,
postconcussion syndrome and multiple sclerosis. The company’s noninvasive
Electroceutical® therapeutic device, SofPulse®, which uses pulsed short-wave
radiofrequency at 27.12 MHz, has been FDA-cleared and CE marked for the
palliative treatment of soft-tissue injuries and postoperative pain and edema
and has CMS national coverage for the treatment of chronic wounds. The
company’s current portfolio of preclinical-stage Electroceuticals® therapeutic
devices addresses chronic kidney disease, liver disease nonalcoholic steatohepatitis
(NASH), cardiovascular and peripheral artery disease (PAD), and ischemic
stroke. The company’s noninvasive, wearable Electroceuticals® therapeutic
devices work by restoring key electrochemical processes that initiate
anti-inflammatory and growth factor cascades necessary for healing to occur.
For more information, visit the company’s website at www.Endonovo.com.
NOTE TO INVESTORS: The latest news and updates
relating to ENDV are available in the company’s newsroom at http://ibn.fm/ENDV
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment